Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)
Standard
Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT). / Beksac, Meral; Kröger, Nicolaus; Byrne, Jennifer L; Ganser, Arnold; Yeğin, Zeynep Arzu; Schönland, Stefan.
In: BONE MARROW TRANSPL, Vol. 56, No. 3, 03.2021, p. 529-531.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)
AU - Beksac, Meral
AU - Kröger, Nicolaus
AU - Byrne, Jennifer L
AU - Ganser, Arnold
AU - Yeğin, Zeynep Arzu
AU - Schönland, Stefan
PY - 2021/3
Y1 - 2021/3
U2 - 10.1038/s41409-020-01010-1
DO - 10.1038/s41409-020-01010-1
M3 - Other (editorial matter etc.)
C2 - 32741961
VL - 56
SP - 529
EP - 531
JO - BONE MARROW TRANSPL
JF - BONE MARROW TRANSPL
SN - 0268-3369
IS - 3
ER -